UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.43-69

2021

Volltextzugriff (PDF)

Hyperphagia and Central Mechanisms for Leptin Resistance during Pregnancy

Endocrinology (Philadelphia), 2011-04, Vol.152 (4), p.1355-1365

2011

Volltextzugriff (PDF)

Variabilidad glucémica en la diabetes tipo 2: influencia sobre el deterioro cognitivo

Revista española de geriatría y gerontología, 2018-06, Vol.53, p.79-79

2018

Volltextzugriff (PDF)

Hyperphagia and Central Mechanisms for Leptin Resistance during Pregnancy

The journal of clinical endocrinology and metabolism, 2011-03, Vol.96 (3), p.869-869

2011

Volltextzugriff (PDF)

Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I

The Journal of neuroscience, 2005-11, Vol.25 (47), p.10884-10893

2005

Volltextzugriff (PDF)

Megalin mediates the transport of leptin across the blood-CSF barrier

Neurobiology of aging, 2008-06, Vol.29 (6), p.902-912

2008

Volltextzugriff (PDF)

Protection by gelsolin on amyloid-b-induced toxicity in the blood-CSF-brain barrier: Apoptotic pathways

Journal of the neurological sciences, 2009, Vol.283 (1), p.299-299

2009

Volltextzugriff (PDF)

Induction of angiogenesis by implantation of encapsulated cells expressing vegf: A new therapy approach on Alzheimer's disease?

Journal of the neurological sciences, 2009, Vol.283 (1), p.260-260

2009

Volltextzugriff (PDF)

P.076 Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program

European neuropsychopharmacology, 2019-12, Vol.29, p.S71-S72

2019

Volltextzugriff (PDF)

P.075 Proteomics in schizophrenia: A gateway to discover potential biomarkers of synaptic, neuronal and neurotransmission pathways

European neuropsychopharmacology, 2019-12, Vol.29, p.S70-S71

2019

Volltextzugriff (PDF)

Ghrelin improves growth hormone responses to growth hormone-releasing hormone in a streptozotocin-diabetic model of delayed onset

Journal of endocrinological investigation, 2007-04, Vol.30 (4), p.298-305

2007

Volltextzugriff (PDF)

Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor

Journal of cell science, 2009-09, Vol.122 (18), p.3351-3357

2009

Volltextzugriff (PDF)

P.2.e.004 - Electroconvulsive therapy: changes in the proteomic profiling in non-responder patients with major depresion

European neuropsychopharmacology, 2017-10, Vol.27, p.S842-S842

2017

Volltextzugriff (PDF)

Proteomic profiling changes induced by physical activity in patients with schizophrenia

European neuropsychopharmacology, 2017-10, Vol.27, p.S964-S965

2017

Volltextzugriff (PDF)

Electroconvulsive therapy: changes in the proteomic profiling in non-responder patients with major depresion

European neuropsychopharmacology, 2017-10, Vol.27, p.S842

2017

Volltextzugriff (PDF)

P.3.e.003 - Proteomic profiling changes induced by physical activity in patients with schizophrenia

European neuropsychopharmacology, 2017-10, Vol.27, p.S964-S965

2017

Volltextzugriff (PDF)

Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures

Endocrine, 2006-04, Vol.29 (2), p.317-324

2006

Volltextzugriff (PDF)

Heparin increases prolactin and modifies the effects of fgf-2 upon prolactin accumulation in pituitary primary cultures

Endocrine, 2004-07, Vol.24 (2), p.131-136

2004

Volltextzugriff (PDF)

Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

International journal of molecular sciences, 2022-09, Vol.23 (17), p.9583

2022

Volltextzugriff (PDF)

Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship

Schizophrenia research, 2018-07, Vol.197, p.19-33

2018

Volltextzugriff (PDF)

Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

Neural regeneration research, 2024-08, Vol.19 (8), p.1671-1677

2024

Volltextzugriff (PDF)

Schizophrenia: A review of potential biomarkers

Journal of psychiatric research, 2017-10, Vol.93, p.37-49

2017

Volltextzugriff (PDF)

Tuning the drug multimodal release through a co-assembly strategy based on magnetic gels

Nanoscale, 2022-04, Vol.14 (14), p.5488-55

2022

Volltextzugriff (PDF)

An Injectable Composite Co‐Assembled Dehydropeptide‐Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy

Advanced functional materials, 2024-05

2024

Volltextzugriff (PDF)

P1‐533: DO BIOMARKERS DIFFERENTIATE COGNITIVE PROFILES IN MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE?

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_9), p.P536-P537

2018

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis

Hyperphagia and Central Mechanisms for Leptin Resistance during Pregnancy

Variabilidad glucémica en la diabetes tipo 2: influencia sobre el deterioro cognitivo

Hyperphagia and Central Mechanisms for Leptin Resistance during Pregnancy

Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I

Megalin mediates the transport of leptin across the blood-CSF barrier

Protection by gelsolin on amyloid-b-induced toxicity in the blood-CSF-brain barrier: Apoptotic pathways

Induction of angiogenesis by implantation of encapsulated cells expressing vegf: A new therapy approach on Alzheimer's disease?

P.076 Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program

P.075 Proteomics in schizophrenia: A gateway to discover potential biomarkers of synaptic, neuronal and neurotransmission pathways

Ghrelin improves growth hormone responses to growth hormone-releasing hormone in a streptozotocin-diabetic model of delayed onset

Ligand-independent signaling by disulfide-crosslinked dimers of the p75 neurotrophin receptor

P.2.e.004 - Electroconvulsive therapy: changes in the proteomic profiling in non-responder patients with major depresion

Proteomic profiling changes induced by physical activity in patients with schizophrenia

Electroconvulsive therapy: changes in the proteomic profiling in non-responder patients with major depresion

P.3.e.003 - Proteomic profiling changes induced by physical activity in patients with schizophrenia

Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures

Heparin increases prolactin and modifies the effects of fgf-2 upon prolactin accumulation in pituitary primary cultures

Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship

Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

Schizophrenia: A review of potential biomarkers

Tuning the drug multimodal release through a co-assembly strategy based on magnetic gels

An Injectable Composite Co‐Assembled Dehydropeptide‐Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy

P1‐533: DO BIOMARKERS DIFFERENTIATE COGNITIVE PROFILES IN MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE?

Suchergebnisse filtern